Abstract
The introduction of the triptans was a major step forward in migraine therapy. Many migrainous patients, however, do not respond satisfactorily,1 which leaves room for improvement. Abouch Krymchantowski and colleagues2 recently reported a study in which they investigated the combination of the gastrokinetic drug, trimebutine,3 and rizatriptan for the treatment of migraine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
